This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its specific structure makes it valuable in the production of drugs targeting the central nervous system, particularly those used for treating psychiatric and neurological disorders. The compound's chiral center and functional groups allow for the development of enantiomerically pure substances, which are crucial for ensuring the efficacy and safety of medications. Additionally, it may be employed in research settings for studying receptor interactions and developing new therapeutic agents with improved selectivity and reduced side effects.